Ambrisentan is a novel highly selective endothelin receptor antagonist for the treatment of pulmonary arterial hypertension.

June 21, 2017

prudect name : Ambrisentan is a novel highly selective endothelin receptor antagonist for the treatment of pulmonary arterial hypertension.
Ambrisentan

Synonyms: CAS NO: 177036-94-1Molecular Formula: C₂₂H₂₂N₂O₄Molecular Weight: 378.43Purity: ≥99%Solubility: Storage: −20°C 2 years

1300031-49-5 References PubMed ID：:http://www.ncbi.nlm.nih.gov/pubmed/18499565